

* Deal could be worth up to $5.76 billion to Eisai * Eisai's drug Lenvima already approved in dozens of countries * Lenvima sales could top $1 bln 8


March 7 (Reuters) - Merck & Co and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell Eisai...